Not surprisingly, PhRMA was not alone in objecting to the one-sided article on clinical trials which was recently featured on the front page of the
Most Recent Posts
In November, the President's Council of Advisors on Science and Technology (PCAST) issued a report focusing on what they view as the necessary steps to
Yesterday the Congressional Budget Office (CBO) released a report describing revised methodology for estimating the fi
In honor of National Diabetes Awareness Month, we want to share with you the story of a recently diagnosed Type II Diabetes patient and her experience with a prescription assistance program:
This week I'm in Boston attending the Harvard Personalized Medicine Conference.
AFLCIO.org profiled the successful partnership between organized labor and the biopharmaceutical industry as they work together to foster good jobs and help increase access to high-quality affordable health care.
Below is the latest guest post in our "Part D Perspectives" series, which we'll be hosting during the 2013 Medicare Part D Open Enrollment Period (Oct. 12 - Dec. 7).
Clinical trials are a critical part of the development of innovative medicines that deliver life-saving benefits to patients.
As one of the founders of a global clinical research organization (CRO) and as current Chair of ACRO, the trade association for CROs, I can assure you that the pharmaceutical, biotechnology and CRO industries are dedicated to the protection, safety, priv